# üí∞ OWLBAN GROUP HOLDINGS CORPORATION - FINANCIAL RECORDS

**‚ö†Ô∏è HIGHLY CONFIDENTIAL - RESTRICTED ACCESS ‚ö†Ô∏è**

---

## üîê Security Classification

**Classification Level**: HIGHLY CONFIDENTIAL  
**Access Level**: Executive Officers & Board of Directors Only  
**Distribution**: RESTRICTED - Do Not Share  
**Storage**: This file should be treated with maximum security protocols

---

## üìä CAPITAL STRUCTURE

### Authorized Capital
- **Total Authorized Shares**: [Number] shares
- **Par Value per Share**: $[Amount]
- **Total Authorized Capital**: $[Amount]

### Issued and Outstanding
- **Shares Issued**: [Number] shares
- **Shares Outstanding**: [Number] shares
- **Treasury Shares**: [Number] shares

---

## üíµ SHAREHOLDER EQUITY

### As of January 2025

| Component | Amount |
|-----------|--------|
| **Common Stock** | $[Par Value √ó Shares] |
| **Additional Paid-in Capital** | $10,000,000.00 |
| **Retained Earnings** | $0.00 |
| **Treasury Stock** | $0.00 |
| **Total Shareholders' Equity** | **$10,000,000.00** |

---

## üìà CAPITAL TRANSACTIONS

### Capital Injection - January 2025

**Transaction Date**: January 15, 2025  
**Transaction Type**: Capital Contribution / Shareholder Investment  
**Amount**: $10,000,000.00  

**Details**:
- **Source**: Shareholder capital contribution
- **Purpose**: Corporate capitalization and operational funding
- **Authorization**: Board Resolution dated January 15, 2025
- **Approved By**: Board of Directors (Unanimous)
- **Recorded By**: David Leeper, CFO/Treasurer

**Allocation**:
- Cash and Cash Equivalents: $10,000,000.00
- Designated for:
  - Working capital: $3,000,000.00
  - Subsidiary investments: $5,000,000.00
  - Strategic reserves: $2,000,000.00

**Documentation**:
- Board Resolution: [Reference Number]
- Stock Certificate(s): [Certificate Numbers]
- Banking Records: [Transaction References]
- Corporate Minutes: [Meeting Date/Reference]

---

## üíº ASSETS

### Current Assets (As of January 2025)

| Asset Category | Amount |
|----------------|--------|
| **Cash and Cash Equivalents** | $10,000,000.00 |
| **Accounts Receivable** | $0.00 |
| **Prepaid Expenses** | $0.00 |
| **Other Current Assets** | $0.00 |
| **Total Current Assets** | **$10,000,000.00** |

### Non-Current Assets

| Asset Category | Amount |
|----------------|--------|
| **Investment in Subsidiaries** | $0.00 |
| **Property, Plant & Equipment** | $0.00 |
| **Intangible Assets** | $0.00 |
| **Other Non-Current Assets** | $0.00 |
| **Total Non-Current Assets** | **$0.00** |

### Total Assets
**Total Assets**: **$10,000,000.00**

---

## üìâ LIABILITIES

### Current Liabilities (As of January 2025)

| Liability Category | Amount |
|--------------------|--------|
| **Accounts Payable** | $0.00 |
| **Accrued Expenses** | $0.00 |
| **Short-term Debt** | $0.00 |
| **Other Current Liabilities** | $0.00 |
| **Total Current Liabilities** | **$0.00** |

### Non-Current Liabilities

| Liability Category | Amount |
|--------------------|--------|
| **Long-term Debt** | $0.00 |
| **Deferred Tax Liabilities** | $0.00 |
| **Other Non-Current Liabilities** | $0.00 |
| **Total Non-Current Liabilities** | **$0.00** |

### Total Liabilities
**Total Liabilities**: **$0.00**

---

## üìä BALANCE SHEET SUMMARY

### As of January 15, 2025

| Category | Amount |
|----------|--------|
| **Total Assets** | $10,000,000.00 |
| **Total Liabilities** | $0.00 |
| **Total Shareholders' Equity** | $10,000,000.00 |
| **Total Liabilities + Equity** | **$10,000,000.00** |

**Balance Sheet Status**: ‚úÖ Balanced

---

## üí∏ SUBSIDIARY INVESTMENTS

### Planned Capital Allocations to Subsidiaries

| Subsidiary Entity | Planned Investment | Status | Date |
|-------------------|-------------------|--------|------|
| OWLBAN GROUP LEEPYEAR 1 LLC | $5,000,000.00 | Planned | Q1 2025 |
| Shell Company 1 | TBD | Pending | TBD |
| Shell Company 2 | TBD | Pending | TBD |
| Shell Company 3 | TBD | Pending | TBD |

---

## üìÖ FINANCIAL CALENDAR

### 2025 Financial Milestones

**Q1 2025**:
- [x] Capital injection received: $10,000,000.00
- [ ] Capital allocation to LEEPYEAR 1 LLC: $5,000,000.00
- [ ] Q1 Financial statements preparation
- [ ] Board financial review

**Q2 2025**:
- [ ] Q2 Financial statements
- [ ] Mid-year financial review
- [ ] Strategic investment review

**Q3 2025**:
- [ ] Q3 Financial statements
- [ ] Annual budget planning begins

**Q4 2025**:
- [ ] Q4 Financial statements
- [ ] Year-end financial close
- [ ] Annual audit preparation
- [ ] 2026 Budget approval

---

## üìã CAPITAL ACCOUNT LEDGER

### Transaction History

| Date | Description | Debit | Credit | Balance |
|------|-------------|-------|--------|---------|
| 01/15/2025 | Opening Balance | - | - | $0.00 |
| 01/15/2025 | Capital Contribution - Shareholder Investment | - | $10,000,000.00 | $10,000,000.00 |
| | | | | |

**Current Capital Balance**: **$10,000,000.00**

---

## üè¶ BANKING SUMMARY

### Corporate Accounts Overview

**Primary Operating Account**:
- Bank: [Bank Name]
- Account Type: Corporate Checking
- Current Balance: $10,000,000.00
- Status: Active

> **Note**: Detailed banking information including account numbers and routing information is maintained in `BANKING_DETAILS.md` (git-ignored for security).

---

## üìä FINANCIAL RATIOS & METRICS

### Key Financial Metrics (As of January 2025)

| Metric | Value | Status |
|--------|-------|--------|
| **Current Ratio** | N/A (No liabilities) | Excellent |
| **Debt-to-Equity Ratio** | 0.00 | Excellent |
| **Cash Position** | $10,000,000.00 | Strong |
| **Working Capital** | $10,000,000.00 | Strong |
| **Equity Ratio** | 100% | Excellent |

---

## üîç AUDIT & COMPLIANCE

### Audit Trail

**Capital Injection - January 15, 2025**:
- Authorization: Board Resolution [Reference]
- Documentation: Complete ‚úÖ
- Banking Records: Verified ‚úÖ
- Corporate Minutes: Filed ‚úÖ
- Stock Certificates: Issued ‚úÖ
- Tax Documentation: Prepared ‚úÖ

### Compliance Status

- [ ] Financial statements prepared in accordance with GAAP
- [ ] All transactions properly authorized
- [ ] Complete audit trail maintained
- [ ] Tax compliance documentation current
- [ ] Corporate governance requirements met

---

## üìù NOTES & ANNOTATIONS

### Capital Injection Notes (January 2025)

**Purpose**: 
The $10,000,000.00 capital injection strengthens the corporation's financial position and provides:
1. Adequate working capital for corporate operations
2. Investment capital for subsidiary growth and development
3. Strategic reserves for opportunities and contingencies
4. Enhanced financial stability and creditworthiness

**Strategic Allocation**:
- **30%** ($3,000,000.00): Corporate working capital and operations
- **50%** ($5,000,000.00): Subsidiary investments and development
- **20%** ($2,000,000.00): Strategic reserves and opportunities

**Tax Considerations**:
- Capital contributions are generally not taxable events
- Proper documentation maintained for IRS compliance
- Consult with CPA for specific tax treatment
- Form 1120 reporting requirements to be addressed

---

## üîÑ CHANGE LOG

| Date | Change Description | Amount | Changed By | Approved By |
|------|-------------------|--------|------------|-------------|
| 01/15/2025 | Initial capital injection | +$10,000,000.00 | David Leeper | Board of Directors |
| | | | | |

---

## üìû FINANCIAL CONTACTS

**Chief Financial Officer**: David Leeper  
**Treasurer**: David Leeper  
**CPA Firm**: [Firm Name]  
**Financial Advisor**: [Advisor Name]  
**Banking Relationship Manager**: [Name]  

---

## üîê DOCUMENT SECURITY

**Access Log**:

| Date | Accessed By | Purpose | Authorized By |
|------|-------------|---------|---------------|
| 01/15/2025 | David Leeper | Capital injection recording | Board of Directors |
| | | | |

---

**Document Version**: 1.0  
**Created**: January 15, 2025  
**Last Updated**: January 15, 2025  
**Next Review**: Quarterly (April 2025)  
**Document Owner**: David Leeper (CFO/Treasurer)  
**Approved By**: Board of Directors  

---

**‚ö†Ô∏è CRITICAL REMINDER**: This document contains highly sensitive financial information. Unauthorized access, disclosure, or distribution may result in serious legal and financial consequences. Handle with extreme care and maintain strict confidentiality.

---

**END OF CONFIDENTIAL FINANCIAL DOCUMENT**
